HAGGERTY POLICY SOLUTIONS for CALIFORNIA LIFE SCIENCES
What was lobbied
8 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
User fee reauthorization (HR 7667) (S.4535) (S.4348) - Prescription drug, Biosimilars, and medical device user fee program reauthorization, accelerated approval, importation, lab test issues Inflation Reduction Act (S.3495) - drug pricing, Medicare and Medicaid coverage of prescription drugs Intellectual property - patents, "march-in" rights Tax and trade issues - SBIR, SBA, compulsory licensing, international pricing issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEANNE HAGGERTY New | — |
Copyright/Patent/Trademark CPT
User fee reauthorization (HR 7667) (S.4535) (S.4348) - Prescription drug, Biosimilars, and medical device user fee program reauthorization, accelerated approval, importation, lab test issues Inflation Reduction Act (S.3495) - drug pricing, Medicare and Medicaid coverage of prescription drugs Intellectual property - patents, "march-in" rights Tax and trade issues - SBIR, SBA, compulsory licensing, international pricing issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEANNE HAGGERTY New | — |
Medical/Disease Research/Clinical Labs MED
User fee reauthorization (HR 7667) (S.4535) (S.4348) - Prescription drug, Biosimilars, and medical device user fee program reauthorization, accelerated approval, importation, lab test issues Inflation Reduction Act (S.3495) - drug pricing, Medicare and Medicaid coverage of prescription drugs Intellectual property - patents, "march-in" rights Tax and trade issues - SBIR, SBA, compulsory licensing, international pricing issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEANNE HAGGERTY New | — |
Medicare/Medicaid MMM
User fee reauthorization (HR 7667) (S.4535) (S.4348) - Prescription drug, Biosimilars, and medical device user fee program reauthorization, accelerated approval, importation, lab test issues Inflation Reduction Act (S.3495) - drug pricing, Medicare and Medicaid coverage of prescription drugs Intellectual property - patents, "march-in" rights Tax and trade issues - SBIR, SBA, compulsory licensing, international pricing issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEANNE HAGGERTY New | — |
Pharmacy PHA
User fee reauthorization (HR 7667) (S.4535) (S.4348) - Prescription drug, Biosimilars, and medical device user fee program reauthorization, accelerated approval, importation, lab test issues Inflation Reduction Act (S.3495) - drug pricing, Medicare and Medicaid coverage of prescription drugs Intellectual property - patents, "march-in" rights Tax and trade issues - SBIR, SBA, compulsory licensing, international pricing issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEANNE HAGGERTY New | — |
Taxation/Internal Revenue Code TAX
User fee reauthorization (HR 7667) (S.4535) (S.4348) - Prescription drug, Biosimilars, and medical device user fee program reauthorization, accelerated approval, importation, lab test issues Inflation Reduction Act (S.3495) - drug pricing, Medicare and Medicaid coverage of prescription drugs Intellectual property - patents, "march-in" rights Tax and trade issues - SBIR, SBA, compulsory licensing, international pricing issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEANNE HAGGERTY New | — |
Science/Technology SCI
User fee reauthorization (HR 7667) (S.4535) (S.4348) - Prescription drug, Biosimilars, and medical device user fee program reauthorization, accelerated approval, importation, lab test issues Inflation Reduction Act (S.3495) - drug pricing, Medicare and Medicaid coverage of prescription drugs Intellectual property - patents, "march-in" rights Tax and trade issues - SBIR, SBA, compulsory licensing, international pricing issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEANNE HAGGERTY New | — |
Trade (domestic/foreign) TRD
User fee reauthorization (HR 7667) (S.4535) (S.4348) - Prescription drug, Biosimilars, and medical device user fee program reauthorization, accelerated approval, importation, lab test issues Inflation Reduction Act (S.3495) - drug pricing, Medicare and Medicaid coverage of prescription drugs Intellectual property - patents, "march-in" rights Tax and trade issues - SBIR, SBA, compulsory licensing, international pricing issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEANNE HAGGERTY New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.